Clinical Trials · NCT00948818

Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation

Name: Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Linaclotide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Forest Laboratories
Enrollment: 803
Start date: Jul 2009
Locations: 118 sites, United States, Canada
Primary endpoint: Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 9 Out of 12 Weeks

View Linaclotide compound reference